P&G stock slides again after Wells Fargo cuts target — what investors watch next
6 January 2026
1 min read

P&G stock slides again after Wells Fargo cuts target — what investors watch next

NEW YORK, January 5, 2026, 21:15 EST — Market closed

  • Procter & Gamble shares fell about 1% on Monday, extending a five-session slide.
  • Wells Fargo cut its price target to $158 from $170 while keeping an Overweight rating.
  • Next catalysts include U.S. jobs data (Jan. 9) and P&G’s quarterly results (Jan. 22).

Procter & Gamble (PG.N) shares ended down about 1% on Monday at $140.37 after Wells Fargo cut its price target to $158 from $170 and kept an Overweight rating on the stock. 1

The move marked P&G’s fifth straight daily decline and left the stock about 22% below its 52-week high. Trading volume was about 12.1 million shares, above its 50-day average of 9.6 million. 2

The slide came on a strong day for the broader market, with the S&P 500 up 0.64% and the Dow up 1.23%. P&G also moved largely in step with parts of the defensive complex, with Johnson & Johnson and Colgate-Palmolive also lower. 3

Rate expectations are back in focus in early January, and that matters for steady cash-flow names such as P&G. “What keeps us awake at night is that inflation risk has resurfaced,” Julius Bendikas, European head of economics and dynamic asset allocation at Mercer, told Reuters. 4

Wells Fargo’s price-target cut brings its view to roughly 13% above Monday’s close, but P&G is still trading near the lower end of its 52-week range, with a low of $138.14. A price target is an analyst’s estimate of where a stock could trade over the next year; “Overweight” signals a preference versus peers in that coverage universe. 5

Macro data in the coming sessions could move bond yields and shift the market’s appetite for defensive shares. The December U.S. employment report is due on January 9, followed by December CPI on January 13, according to the Labor Department’s release calendar. 6

The Federal Reserve’s next policy meeting is scheduled for January 27-28, a focal point for equity valuations as investors debate how quickly rate cuts can resume. 7

Company-specific attention turns to P&G’s quarterly results, where investors typically look for updates on pricing versus volumes, input-cost trends, and any changes to management’s outlook. The stock’s recent drift toward its 52-week low has also put technical support in view around the high-$130s. 5

But the set-up cuts both ways: if results show weaker demand, heavier promotions, or margin pressure, P&G risks breaking below support levels and slipping further out of favor as investors rotate toward faster-growing corners of the market.

P&G is scheduled to report fiscal second-quarter earnings on January 22 and host a conference call at 8:30 a.m. ET. 8

Stock Market Today

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
GE Aerospace stock hits a fresh high — what investors are watching before earnings
Previous Story

GE Aerospace stock hits a fresh high — what investors are watching before earnings

AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV
Next Story

AbbVie stock slides 4% as pharma lags Wall Street rally — what investors watch next for ABBV

Go toTop